Get the Stockscreener App
34.73
0.03%
0.010
Sanara Medtech Inc stock is traded at $34.73, with a volume of 541.69K.
It is up +0.03% in the last 24 hours and up +1.97% over the past month.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
See More
Previous Close:
$34.72
Open:
$34.62
24h Volume:
541.69K
Relative Volume:
2.95
Market Cap:
$319.10M
Revenue:
$103.14M
Net Income/Loss:
$-5.82M
P/E Ratio:
-7.9791
EPS:
-4.3526
Net Cash Flow:
$2.14M
1W Performance:
+0.46%
1M Performance:
+1.97%
6M Performance:
+72.87%
1Y Performance:
+2.03%
1-Day Range:
$34.62
$34.79
1-Week Range:
$34.51
$34.95
52-Week Range:
$16.05
$35.95
Sanara Medtech Inc Stock (SMTI) Company Profile
Name
Sanara Medtech Inc
Sector
Industry
Phone
817-529-2300
Address
1200 SUMMIT AVE, FORT WORTH
Compare SMTI vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SMTI
Sanara Medtech Inc
|
34.73 | 314.60M | 103.14M | -5.82M | 2.14M | -4.3526 |
ISRG
Intuitive Surgical Inc
|
366.70 | 132.30B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
184.74 | 51.11B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
70.50 | 35.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
228.35 | 32.95B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
36.59 | 28.58B | 29.14B | 1.07B | 1.05B | 1.1956 |
Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-26 | Initiated | Lake Street | Buy |
| Mar-26-25 | Reiterated | H.C. Wainwright | Buy |
| Dec-23-24 | Initiated | H.C. Wainwright | Buy |
| May-20-22 | Resumed | Cantor Fitzgerald | Overweight |
| Jun-30-21 | Initiated | Cantor Fitzgerald | Overweight |
Sanara Medtech Inc Stock (SMTI) Latest News
Sanara MedTech (SMTI) agrees to MiMedx takeover, targeting year-end close - Stock Titan
Sanara MedTech Inc. (NASDAQ:SMTI) Short Interest Update - MarketBeat
Walleye Capital LLC Makes New $719,000 Investment in Sanara MedTech Inc. $SMTI - MarketBeat
SMTI Q1 2026 Earnings: Positive EPS Surprise Overcomes Expected LossOne-Time Gain Impact - vinanet.vn
Sanara MedTech (SMTI) Stock Stays Quiet As Profitability Meets Debt Scrutiny - Sahm
(SMTI) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Sanara Medtech earnings missed by $0.02, revenue fell short of estimates - Investing.com Canada
Sanara Medtech Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates - Yahoo Finance
Sanara MedTech (NASDAQ:SMTI) Issues Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat
Sanara MedTech Q2 Results: Sales Rise 9% YoY, EPS Misses Estimate - scanx.trade
Sanara MedTech Inc. Q2 2026: Revenue $28.14M, EPS $(0.05) — 10-Q Summary - TradingView
Sanara MedTech (SMTI) grows H1 2026 revenue to $55.9M and trims loss - Stock Titan
MiMedx Group (SMTI partner) clarifies Sanara merger fees and $33 cash-plus-stock deal - Stock Titan
Form 8K Sanara Medtech Inc For: 11 August By Investing.com - Investing.com Nigeria
Sanara MedTech Corrects Termination Fees in Merger Deal with MiMedx - Kalkine Media
Sanara MedTech Inc. (SMTI) Releases Q2 2026 Earnings: Revenue Rises 8.9% - Quiver Quantitative
Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock merger terms and corrects fees - Stock Titan
Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) - The Manila Times
Sanara MedTech Q2 revenue rises on soft-tissue product growth - TradingView
Sanara MedTech (SMTI) grows revenue, posts Q2 loss amid pending MIMEDX deal - Stock Titan
Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock per share in merger - Stock Titan
Sanara MedTech, Inc. (SMTI) Investigation: Bronstein, Gewirtz & G - The National Law Review
Sanara Medtech Inc expected to post a loss of 2 cents a shareEarnings Preview - TradingView
Sanara MedTech Inc. (NASDAQ:SMTI) Receives Consensus Recommendation of "Reduce" from Analysts - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Sanara MedTec - The National Law Review
Sanara MedTech (SMTI) Expected to Post Earnings on Wednesday - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech Inc - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech, Inc - The National Law Review
Sanara MedTech (NASDAQ:SMTI) Stock Rating Lowered by Freedom Capital - MarketBeat
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc.SMTI - marketscreener.com
How (SMTI) Movements Inform Risk Allocation Models - Stock Traders Daily
Sanara MedTech (SMTI) Holds Near $33.86 as Support Levels Come into FocusDiagonal Spread Trade - vinanet.vn
SANARA MEDTECH INC : H.C. WAINWRIGHT CUTS TO NEUTRAL FROM BUY; CUTS TARGET PRICE TO $35 FROM $36 - webull.com
Mimedx to buy Sanara for $350M to move beyond wound care - bioworld.com
Is There Now An Opportunity In Sanara MedTech Inc. (NASDAQ:SMTI)? - webull.com
MiMedx to Buy Sanara MedTech for $350M - Medical Product Outsourcing
Sanara MedTech (SMTI) agrees to $350 million cash‑and‑stock acquisition by MiMedx - Stock Titan
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ), Sanara MedTech Inc. (Nasdaq – SMTI), TriCo Bancshares (Nasdaq – TCBK) - GlobeNewswire
MIMEDX To Acquire Sanara MedTech In $350 Million Transaction - Pulse 2.0
MiMedx Group: Sanara Deal Comes At A Poor Time - Seeking Alpha
SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders - The AI Journal
Sanara MedTech agrees to be acquired by MiMedx - TipRanks
MIMEDX to acquire Sanara MedTech for $350 million By Investing.com - Investing.com Nigeria
Sanara MedTech to Be Acquired by MiMedx in $35-Per-Share Cash-and-Stock Merger - TradingView
MiMedx Q2 sales fall less than expected; set to acquire Sanara MedTech - TradingView
MIMEDX to Acquire Sanara MedTech - The Manila Times
MIMEDX Announces Second Quarter 2026 Operating & Financial Results - GlobeNewswire
MiMedx Group, Inc. entered into a definitive merger agreement to acquire Sanara MedTech Inc. for approximately $340 million. - marketscreener.com
Sanara MedTech Inc. Revenue Breakdown – NASDAQ:SMTI - TradingView
Sanara Medtech Inc Stock (SMTI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.76%
1.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):